These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22329800)

  • 1. Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.
    Liu Z; Yan R; Al-Salman A; Shen Y; Bu Y; Ma J; Luo DX; Huang C; Jiang Y; Wilber A; Mo YY; Huang MC; Zhao Y; Cao D
    Biochem J; 2012 Mar; 442(2):273-82. PubMed ID: 22329800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.
    Cheng BY; Lau EY; Leung HW; Leung CO; Ho NP; Gurung S; Cheng LK; Lin CH; Lo RC; Ma S; Ng IO; Lee TK
    Cancer Res; 2018 May; 78(9):2332-2342. PubMed ID: 29483095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
    Sato S; Genda T; Hirano K; Tsuzura H; Narita Y; Kanemitsu Y; Kikuchi T; Iijima K; Wada R; Ichida T
    Liver Int; 2012 Oct; 32(9):1382-90. PubMed ID: 22681639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinoma.
    Ha SY; Song DH; Lee JJ; Lee HW; Cho SY; Park CK
    Gut Liver; 2014 Nov; 8(6):648-54. PubMed ID: 25287169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
    Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.
    Liu Z; Zhong L; Krishack PA; Robbins S; Cao JX; Zhao Y; Chung S; Cao D
    Gene; 2009 May; 437(1-2):39-44. PubMed ID: 19236911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aldo-keto reductase family 1 B10 participates in the regulation of hepatoma cell cycle through p27/p-Rb signaling pathway].
    Geng N; Jin YY; Zhu SX; Li YR; Zheng LY; Zhu WJ; Li YW; Han C; Dou XG; Bai H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):861-867. PubMed ID: 33105932
    [No Abstract]   [Full Text] [Related]  

  • 8. SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer.
    Kim SY; Shen Q; Son K; Kim HS; Yang HD; Na MJ; Shin E; Yu S; Kang K; You JS; Yu KR; Jeong SM; Lee EK; Ahn YM; Park WS; Nam SW
    Oncogene; 2021 Jul; 40(28):4652-4662. PubMed ID: 34140644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of aldo-keto reductase AKR1B10 gene expression by a phorbol ester via the ERK/c-Jun signaling pathway.
    Nishinaka T; Miura T; Sakou M; Hidaka C; Sasaoka C; Okamura A; Okamoto A; Terada T
    Chem Biol Interact; 2015 Jun; 234():274-81. PubMed ID: 25463304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras-E-cadherin pathway.
    Zhang W; Li H; Yang Y; Liao J; Yang GY
    Cancer Lett; 2014 Dec; 355(2):273-80. PubMed ID: 25304374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions.
    Matkowskyj KA; Bai H; Liao J; Zhang W; Li H; Rao S; Omary R; Yang GY
    Hum Pathol; 2014 Apr; 45(4):834-43. PubMed ID: 24656094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
    Sato S; Genda T; Ichida T; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Nagahara A; Watanabe S
    J Gastroenterol Hepatol; 2016 Jul; 31(7):1315-22. PubMed ID: 26758591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of 14-3-3ε, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma.
    Wu CY; Jan YJ; Ko BS; Wu YJ; Wu YJ; Liou JY
    Anticancer Res; 2018 Dec; 38(12):6855-6863. PubMed ID: 30504401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of aldo-keto reductase AKR1B10 gene expression: involvement of transcription factor Nrf2.
    Nishinaka T; Miura T; Okumura M; Nakao F; Nakamura H; Terada T
    Chem Biol Interact; 2011 May; 191(1-3):185-91. PubMed ID: 21277289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis.
    Tsuzura H; Genda T; Sato S; Murata A; Kanemitsu Y; Narita Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Ichida T
    Int J Mol Sci; 2014 Apr; 15(4):6556-68. PubMed ID: 24747592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumours.
    Heringlake S; Hofdmann M; Fiebeler A; Manns MP; Schmiegel W; Tannapfel A
    J Hepatol; 2010 Feb; 52(2):220-7. PubMed ID: 20036025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of aldo-keto-reductase family 1 B10 by 14-3-3ε and their prognostic impact of hepatocellular carcinoma.
    Liu TA; Jan YJ; Ko BS; Wu YJ; Lu YJ; Liang SM; Liu CC; Chen SC; Wang J; Shyue SK; Liou JY
    Oncotarget; 2015 Nov; 6(36):38967-82. PubMed ID: 26516929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells.
    Ikari A; Sanada A; Okude C; Sawada H; Yamazaki Y; Sugatani J; Miwa M
    J Cell Physiol; 2010 Mar; 222(3):481-7. PubMed ID: 19937979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of functional antioxidant response elements in the promoter of the aldo-keto reductase AKR1B10 gene.
    Nishinaka T; Miura T; Shimizu K; Terada T
    Chem Biol Interact; 2017 Oct; 276():160-166. PubMed ID: 28219640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elk1 and AP-1 sites in the TBP promoter mediate alcohol-induced deregulation of Pol III-dependent genes.
    Zhong Q; Shi G; Zhang Y; Levy D; Zhong S
    Gene; 2013 Aug; 526(1):54-60. PubMed ID: 23454483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.